These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 814443)

  • 21. [Osteopathy in maintenance hemodialysis (author's transl)].
    Krempien B; Ritz E; Heuck F
    Verh Dtsch Ges Pathol; 1972; 56():439-42. PubMed ID: 4130865
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prevention and therapy of regulatory hyperparathyroidism in kidney patients].
    Koall W; Mampel E; Hintner I; Kokot F
    Z Gesamte Inn Med; 1982 Apr; 37(7):197-201. PubMed ID: 7048771
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of renal osteodystrophy in children with dihydrotachysterol and 24,25-dihydroxyvitamin D3.
    van Diemen-Steenvoorde R; Donckerwolcke RA; Bosch R; Visser WJ; Raymakers JA; Duursma SA
    Clin Nephrol; 1985 Dec; 24(6):292-9. PubMed ID: 3878249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [On the clinical value of roentgenological observation of the clinical course of renal osteopathy (author's transl)].
    Fritsch R; Freyschmidt J; Lustenberger N; Hesch RD
    Rontgenblatter; 1980 May; 33(5):207-16. PubMed ID: 7375764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dialysis bone disease in children. Six cases (author's transl)].
    Luciani JC; Ferran JL; Dumas ML; Meunier P; Dumas R
    Nouv Presse Med; 1977 Nov; 6(39):3616-9. PubMed ID: 607175
    [No Abstract]   [Full Text] [Related]  

  • 26. Can low-dosage aluminium hydroxide control the plasma phosphate without bone toxicity?
    Jenkins DA; Gouldesbrough D; Smith GD; Cowie JF; Winney RJ
    Nephrol Dial Transplant; 1989; 4(1):51-6. PubMed ID: 2494599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Radiological investigations of renal osteodystrophy in children on hemodialysis (author's transl)].
    Bretagne MC; Bloc-Derlon B; Djafari N; André JL; Pierson M; Hoeffel JC
    Ann Radiol (Paris); 1980 Nov; 23(7):579-84. PubMed ID: 7447300
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical problems of renal osteopathy in patients on hemofiltration.
    Schulz W; Baier E; Hümpfner A; Delling G
    Contrib Nephrol; 1982; 32():86-91. PubMed ID: 7128166
    [No Abstract]   [Full Text] [Related]  

  • 29. Reduction in dialysate calcium concentration lowers skin calcium content in patients on chronic hemodialysis.
    Zinn D; Cruz C; Smith D; Potocki M; Parfitt C; Hricak H; Levin NW; Kleerekoper M
    Trans Am Soc Artif Intern Organs; 1980; 26():378-82. PubMed ID: 7245518
    [No Abstract]   [Full Text] [Related]  

  • 30. Azotemic renal osteodystrophy; clinical features and bone pathology.
    Suzuki M; Hirasawa Y
    Endocrinol Jpn; 1979 Jun; 26(Suppl):85-93. PubMed ID: 467354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alkaline phosphatase bone isoenzyme activity in serum in various degrees of micromorphometrically assessed renal osteopathy.
    Siede WH; Seiffert UB; Bundschuh F; Malluche HH; Schoeppe W
    Clin Nephrol; 1980 Jun; 13(6):277-81. PubMed ID: 7408246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone disease in patients dialyzed with untreated water.
    Rashid A; Posen GA; Gray D; Jaworski ZF
    Med Instrum; 1974; 8(3):204-6. PubMed ID: 4838450
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of phosphate binging agents on bone remodelling in patients on regular haemodialysis.
    Fournier A; Tunchot S; Bedrossian J; Sionest JG; Idatte JM; Bordier P
    Proc Eur Dial Transplant Assoc; 1972; 9():126-41. PubMed ID: 4668905
    [No Abstract]   [Full Text] [Related]  

  • 34. [Bone mineral content during chronic hemodialysis long term observation by 125-i photonabsorptiometry (author's transl)].
    Kuhlencordt F; Ringe JD
    Klin Wochenschr; 1978 Jan; 56(2):75-9. PubMed ID: 415174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hydroxylated metabolites of vitamin D. Therapeutic use of calcitriol and dihydrotachysterol].
    Stĕpán J; Lachmanová J; Wilczek H; Straková M; Zichová M; Horn V; Tomásek R; Pacovský V
    Cas Lek Cesk; 1985 Dec; 124(50):1550-6. PubMed ID: 3841297
    [No Abstract]   [Full Text] [Related]  

  • 36. Dihydrotachysterol treatment in renal osteodystrophy; the effect on alkaline and acid phosphatase.
    Van Kesteren RG; Duursma SA; Dorhout Mees EJ
    Neth J Med; 1978; 21(1):17-22. PubMed ID: 634412
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical study of renal osteodystrophy in chronic dialysis patients by means of whole body skeletal scintiphotography (author's transl)].
    Kida T; Narita S
    Kaku Igaku; 1978 Oct; 15(7):1005-11. PubMed ID: 739671
    [No Abstract]   [Full Text] [Related]  

  • 38. [Evaluation of terminal parathormone NH2 and COOH and plasma calcitonin in the blood of uremic patients under hemodialysis therapy].
    Di Landro D; Zanatta GP; Simioni N; Pinzani A; Zotti D; Perin N; Bertoli M; Naso A; Ruffatti A; Gasparotto ML
    Minerva Med; 1985 Mar; 76(9-10):419-23. PubMed ID: 3982699
    [No Abstract]   [Full Text] [Related]  

  • 39. [Radionuclide studies in chronically hemodialyzed patients. Bone scintigraphy for the evaluation and control of renal osteopathy].
    Dudczak R; Kletter K; Czembirek H; Derfler K; Marosi L; Salomonowitz E; Schmidt P; Wurzer G; Zazgornik J
    Wien Klin Wochenschr; 1984 Apr; 96(9):326-32. PubMed ID: 6236616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.